Polycystic ovary syndrome: who works on it

One card per institution. Filter by target, by country, or show only institutions in EU-13 (Horizon Europe widening) countries.

• All targets
• GLP-1 4
• TNF 1
• IL-1 0
• IL-6 0
• BDNF 0
• PNPLA3 1
• SGLT2 0

EU-13 is a filter, not a ranking: it only narrows the list.

No research groups match this view yet.

Terminated, withdrawn and suspended trials with the reason the sponsor gave in the registry, quoted word for word.

• Suspended

  NAFLD in Adolescents and Young Adults With PCOS

  NCT02506946· Columbia University· Updated 30 Sept 2026

  “Lack of funding”Registry text, quoted unchanged. Source

• Terminated

  The REBALANCE Study - a Prospective, Multicenter, Randomized, Pivotal Study of the May Health System

  NCT06206746· May Health· Updated 8 Sept 2026

  “Business decision by sponsor to terminate the study”Registry text, quoted unchanged. Source

• Withdrawn

  Semaglutide and Polycystic Ovarian Syndrome: an Emerging Treatment Strategy

  NCT06222437· Methodist Health System· Updated 23 Mar 2026

  “IRB did not approve”Registry text, quoted unchanged. Source

• Withdrawn

  Relative Desirability of Metformin vs. Birth Control Pill in Treating PCOS in Women of Later Reproductive Age

  NCT03905941· University of Virginia· Updated 23 Feb 2026

  “No funding, time, or personnel to complete this study.”Registry text, quoted unchanged. Source

• Terminated

  Saroglitazar Magnesium 4 mg in the Treatment of Nonalcoholic Fatty Liver Disease (NAFLD) in Women With PCOS (EVIDENCES VII)

  NCT03617263· Zydus Therapeutics Inc.· Updated 18 Dec 2025

  “Sponsor Decision”Registry text, quoted unchanged. Source

• Terminated

  Effect of Hyperandrogenism on IVF Outcomes in PCOS Patients

  NCT05555680· Clinique Ovo· Updated 9 Dec 2025

  “Low recruitment rate”Registry text, quoted unchanged. Source

• Terminated

  Effects of Inositol Alone or Associated With Alpha-lipoic Acid in Polycystic Ovary Syndrome Treatment

  NCT04881851· Universita di Verona· Updated 16 Apr 2025

  “Study treatment products expired”Registry text, quoted unchanged. Source

• Terminated

  Omega 3 Polyunsaturated Fatty Acids (PUFA) or Magnesium in Obese Polycystic Ovary Syndrome Patients

  NCT02521753· Coordinación de Investigación en Salud, Mexico· Updated 1 Apr 2025

  “It was not possible to continue recruiting due to SARSCov2 pandemia. Results obtained at that time were already published”Registry text, quoted unchanged. Source

• Terminated

  Optimising Preconceptual Health in Subfertile PCOS Patients Using a Lifestyle Modification Program

  NCT05084274· Universitair Ziekenhuis Brussel· Updated 15 Mar 2024

  “Co-investigators have left and not been replaced.”Registry text, quoted unchanged. Source

• Withdrawn

  Letrozole Versus Hormonal Preparation in Frozen Cycles of PCOS Patients.

  NCT05168865· Dubai Fertility Center· Updated 20 Feb 2024

  “unexpected slow recruitment and change of center frozen embryo transfer protocol”Registry text, quoted unchanged. Source

Trials whose registry record says individual participant data (IPD) will be shared.

• Astronaut Vision Issues in a Ground Analog Population: Polycystic Ovary Syndrome

  NCT02896452· National Aeronautics and Space Administration (NASA)· Source

• Comparison of the Euploid Rate of Blastocyst Between PPOS and GnRH Antagonist Protocol in Women With PCOS Undergoing PGT-A

  NCT05326087· ShangHai Ji Ai Genetics & IVF Institute· Source

• The Value of LC-MS/MS Detection of Androgen Profiles in the Diagnosis of PCOS: A Prospective, Multicenter Real-world Study

  NCT07916909· Women's Hospital School Of Medicine Zhejiang University· Source

• Time-Restricted Eating as a Dietary Intervention for Polyendocrine Metabolic Ovarian Syndrome (PMOS): Protocol for a Randomized Controlled Trial

  NCT06204965· Joanna Bajerska· Source

• Sodium-Glucose Co-Transporter-2 Inhibitors as Adjuvant Therapy With Letrozole in Induction of Ovulation in Women With Polycystic Ovarian Syndrome

  NCT07589075· Beni-Suef University· Source

• Effects of Glucagon-like Peptide-1 (GLP-1) Agonist in Neuro-reproductive Function in Obese Adolescent Females With Polycystic Ovary Syndrome (PCOS)

  NCT07169136· Nemours Children's Clinic· Source

• Body Fat as Determinant of Female Gonadal Dysfunction

  NCT03841981· Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal· Source

• The Physiological Responses and Adaptation of Brown Adipose Tissue to Chronic Treatment With Beta3-Adrenergic Receptor Agonists

  NCT03049462· National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)· Source

• Mobile Application for Women With Polycystic Ovary Syndrome

  NCT07371364· Istanbul Medipol University Hospital· Source

• The REBALANCE Study - a Prospective, Multicenter, Randomized, Pivotal Study of the May Health System

  NCT06206746· May Health· Source

Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.

See which targets of this disease your abstract mentions, and go to the people working on them.